Skip to content

Exelixis, Inc.

American biotechnology company

EXEL Nasdaq SEC CIK 939767

Follow Exelixis Weekly email: filings, results, news

News

9 stories filed under Exelixis, grouped into ongoing threads

Q2

Thread · 3 stories

Exelixis, Inc. 2026 Q2 - Results - Earnings Call Presentation

Earnings 49 d ago 2 sources

Exelixis, Inc. (EXEL) Q2 2026 Earnings Call Transcript

Earnings 49 d ago

Exelixis Q2 2026 slides: strong earnings, but NET slowdown cuts guidance

Earnings 49 d ago also on NET

More coverage

Exelixis, Inc. (EXEL) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Markets 16 d ago also on WFC

IBD Stock Of The Day Exelixis Hits Earnings Snag — And Then Breaks Out

Earnings 20 d ago

Exelixis: 'Hold' On Zanzalintinib Subpopulation Miss And STELLAR-304 H2 2026 Data

Markets 23 d ago

Exelixis Owners Keep Getting A Bigger Slice Of A Company In Transition

Markets 31 d ago

Exelixis, Valaris, and 3 More Stocks See Action From Activist Investors

Markets 33 d ago also on VAL

Why This Top-Ranked IBD 50 Stock Just Plummeted On Its Earnings

Earnings 49 d ago 2 sources

Next results

NOV4

FY 2026 results

Wednesday · estimated from the filing cadence

Profile

Headquarters: ALAMEDA, CA, United States
Founded: 1994
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)
Website: exelixis.com

Peers

Where this page comes from

Profile · SEC EDGAR, Wikidata

Next results · estimated from the filing cadence (SEC EDGAR)

News · 9 stories clustered from the RSS aggregator